Contact Us: 01282 426380
KM Financial Solutions | UPDATE 2-France’s Sanofi to carve out active drug ingredients business
66476
post-template-default,single,single-post,postid-66476,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-France’s Sanofi to carve out active drug ingredients business

23 Feb UPDATE 2-France’s Sanofi to carve out active drug ingredients business

Posted at 17:07h in News by
0 Likes
Sanofi plans to create a
standalone company dedicated to making active pharmaceutical
ingredients (API), components that are biologically active in a
drug, and will decide whether to list it on Euronext Paris by
2022.

No Comments

Sorry, the comment form is closed at this time.